Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.22 USD | +2.52% | -1.23% | +35.96% |
05-07 | Top Premarket Gainers | MT |
05-06 | Transcript : FibroGen, Inc., Q1 2024 Earnings Call, May 06, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.96% | 118M | |
+33.33% | 49.46B | |
+1.76% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.57% | 26.61B | |
-22.67% | 18.64B | |
+8.22% | 13.16B | |
+29.58% | 12.55B | |
+24.25% | 12.1B |
- Stock Market
- Equities
- FGEN Stock
- News FibroGen, Inc.
- FibroGen : Goldman Sachs Adjusts Price Target for FibroGen to $24 From $28, Maintains Neutral Rating